Nuance Investments LLC Acquires 2,708,097 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nuance Investments LLC grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 25.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,545,981 shares of the medical instruments supplier's stock after acquiring an additional 2,708,097 shares during the period. DENTSPLY SIRONA comprises 10.4% of Nuance Investments LLC's portfolio, making the stock its largest holding. Nuance Investments LLC owned 6.81% of DENTSPLY SIRONA worth $257,103,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in XRAY. Pacer Advisors Inc. boosted its holdings in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Cooke & Bieler LP lifted its holdings in shares of DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after buying an additional 1,244,326 shares in the last quarter. American Century Companies Inc. raised its position in DENTSPLY SIRONA by 38.2% in the fourth quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier's stock worth $73,522,000 after acquiring an additional 1,071,604 shares in the last quarter. Finally, Invenomic Capital Management LP acquired a new stake in DENTSPLY SIRONA in the third quarter valued at $23,724,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on XRAY. Mizuho cut their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Evercore ISI restated an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $23.33.

DENTSPLY SIRONA Trading Down 4.5 %

Shares of NASDAQ XRAY traded down $0.71 during midday trading on Friday, reaching $14.93. 2,436,694 shares of the stock were exchanged, compared to its average volume of 3,093,060. The stock has a 50 day moving average price of $17.62 and a 200-day moving average price of $20.16. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $2.97 billion, a P/E ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52-week low of $14.78 and a 52-week high of $33.22.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.29%. DENTSPLY SIRONA's payout ratio is currently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.